Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Arthritis Care & Research|May 26, 2017
Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid ArthritisLeslie R Harrold, George W Reed, Ani John, et al.Current Medical Research and Opinion|January 6, 2006
Real-world utilization of DMARDs and biologics in rheumatoid arthritis: the RADIUS (Rheumatoid Arthritis Disease-Modifying Anti-Rheumatic Drug Intervention and Utilization Study) studyAllan Gibofsky, William R Palmer, John A Goldman, et al.Clinical Pharmacology and Therapeutics|October 17, 2022
Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop SummarySophie Shubow, Qin Sun, Ai Len Nguyen Phan, et al.Annals of the Rheumatic Diseases|November 13, 2012
Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statementMonika M Schoels, Désirée van der Heijde, Ferdinand C Breedveld, et al.Clinical Rheumatology|April 27, 2018
Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional studyDimitrios A Pappas, Fredrik Nyberg, Joel M Kremer, et al.Annals of the Rheumatic Diseases|August 2, 2011
Treating Rheumatoid Arthritis to Target: multinational recommendations assessment questionnaireBoulos Haraoui, Josef S Smolen, Daniel Aletaha, et al.Annals of the Rheumatic Diseases|November 23, 2012
Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditionsJosef S Smolen, Monika M Schoels, Norihiro Nishimoto, et al.Pageof 6